Clinics in Liver Disease (ISSN 1089-3261) is a prestigious quarterly journal published by Elsevier in the United States, serving as a leading international reference for hepatology. Indexed in the Science Citation Index (SCI), this high-impact publication focuses primarily on comprehensive review articles that synthesize current clinical research, diagnostic advancements, and therapeutic innovations in liver disease. Its scope encompasses a wide array of hepatic conditions, including viral hepatitis, cirrhosis, hepatocellular carcinoma, and fatty liver disease, offering readers critical insights into the latest scientific developments. While the journal maintains a strong academic reputation and high visibility within the field, it operates as a subscription-based, non-open access title, which may limit immediate full-text availability for some readers. Consequently, it is particularly well-suited for clinicians and researchers seeking authoritative overviews and clinical guidance rather than original experimental data, making it an essential resource for staying abreast of evidence-based practices in liver medicine.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com